Literature DB >> 30315940

Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation.

Ellen M Denzen1, Jaime M Preussler1, Elizabeth A Murphy2, K Scott Baker3, Linda J Burns4, Jackie Foster2, Lensa Idossa2, Heather K Moore2, Tammy J Payton2, Darlene Haven2, Balkrishna Jahagirdar5, Naynesh Kamani6, J Douglas Rizzo7, Lizette Salazar8, Barry A Schatz9, Karen L Syrjala3, John R Wingard10, Navneet S Majhail11.   

Abstract

This study aimed to develop a survivorship care plan (SCP) that can be individualized to facilitate long-term follow-up care of hematopoietic cell transplantation (HCT) survivors. A sample SCP was developed that included 2 documents: a treatment summary and preventive care recommendations that combined data on treatment exposures routinely submitted by HCT centers to the Center for International Blood and Marrow Transplant Research (CIBMTR) with long-term follow-up guidelines. Focus groups were conducted by phone to characterize the critical patient-centered elements of the SCP. Focus group eligibility criteria included (1) adult patients >1 year post-HCT and their caregivers (3 groups; n = 22), (2) HCT physicians and advanced practice providers (APPs) (2 groups; n = 14), (3) HCT nurses and social workers (4 groups; n = 17), and (4) community health care professionals (3 groups; n = 24). Transcripts were analyzed for saturation of key themes using NVivo 10 software. Patients and caregivers suggested combining the treatment summary and care guidelines into a single document. They also requested sections on sexual and emotional health and the immune system. Providers wanted the treatment summary to focus only on what they absolutely must know. Themes were similar across healthcare professionals, although screening for psychosocial issues was emphasized more by the nurses and social workers. All preferred to receive the SCP electronically; however, hardcopy was considered necessary for some patients. All felt that the SCP would facilitate appropriate post-HCT care. This study highlights the need for an SCP instrument to facilitate HCT survivorship care. Furthermore, it demonstrates the feasibility and value of engaging HCT recipients, caregivers, and providers in developing an SCP. Their feedback was incorporated into a final SCP that was subsequently tested in a randomized trial.
Copyright © 2018 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Focus groups; Hematologic malignancy; Hematopoietic cell  transplantation; Patient preferences; Survivorship care plan; Treatment summary

Mesh:

Year:  2018        PMID: 30315940      PMCID: PMC6445667          DOI: 10.1016/j.bbmt.2018.10.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  27 in total

1.  Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.

Authors:  Nandita Khera; Barry Storer; Mary E D Flowers; Paul A Carpenter; Yoshihiro Inamoto; Brenda M Sandmaier; Paul J Martin; Stephanie J Lee
Journal:  J Clin Oncol       Date:  2011-12-05       Impact factor: 44.544

Review 2.  Survivorship care plans in research and practice.

Authors:  Talya Salz; Kevin C Oeffinger; Mary S McCabe; Tracy M Layne; Peter B Bach
Journal:  CA Cancer J Clin       Date:  2012-01-12       Impact factor: 508.702

3.  Health information needs and health-related quality of life in a diverse population of long-term cancer survivors.

Authors:  Erin E Kent; Neeraj K Arora; Julia H Rowland; Keith M Bellizzi; Laura P Forsythe; Ann S Hamilton; Ingrid Oakley-Girvan; Ellen B Beckjord; Noreen M Aziz
Journal:  Patient Educ Couns       Date:  2012-09-28

4.  Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

Authors:  John R Wingard; Navneet S Majhail; Ruta Brazauskas; Zhiwei Wang; Kathleen A Sobocinski; David Jacobsohn; Mohamed L Sorror; Mary M Horowitz; Brian Bolwell; J Douglas Rizzo; Gérard Socié
Journal:  J Clin Oncol       Date:  2011-04-04       Impact factor: 44.544

5.  Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.

Authors:  Smita Bhatia; Leslie L Robison; Liton Francisco; Andrea Carter; Yan Liu; Marcia Grant; K Scott Baker; Henry Fung; James G Gurney; Philip B McGlave; Auayporn Nademanee; Norma K C Ramsay; Anthony Stein; Daniel J Weisdorf; Stephen J Forman
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

6.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  Navneet S Majhail; J Douglas Rizzo; Stephanie J Lee; Mahmoud Aljurf; Yoshiko Atsuta; Carmem Bonfim; Linda J Burns; Naeem Chaudhri; Stella Davies; Shinichiro Okamoto; Adriana Seber; Gerard Socie; Jeff Szer; Maria Teresa Van Lint; John R Wingard; Andre Tichelli
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-13       Impact factor: 5.742

7.  Survivorship care plans: prevalence and barriers to use.

Authors:  Sarah A Birken; Deborah K Mayer; Bryan J Weiner
Journal:  J Cancer Educ       Date:  2013-06       Impact factor: 2.037

8.  Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901.

Authors:  Leigh Anne Faul; Gheorghe Luta; Vanessa Sheppard; Claudine Isaacs; Harvey J Cohen; Hyman B Muss; Rachel Yung; Jonathan D Clapp; Eric Winer; Clifford Hudis; Michelle Tallarico; Julhy Wang; William T Barry; Jeanne S Mandelblatt
Journal:  J Cancer Surviv       Date:  2014-06-11       Impact factor: 4.442

9.  Barriers and facilitators to implementing cancer survivorship care plans.

Authors:  Dorothy Dulko; Claire M Pace; Kim L Dittus; Brian L Sprague; Lori A Pollack; Nikki A Hawkins; Berta M Geller
Journal:  Oncol Nurs Forum       Date:  2013-11       Impact factor: 2.172

10.  Factors influencing implementation of a survivorship care plan-a quantitative process evaluation of the ROGY Care trial.

Authors:  Belle H de Rooij; Nicole P M Ezendam; Kim A H Nicolaije; M Caroline Vos; Johanna M A Pijnenborg; Dorry Boll; Roy F P M Kruitwagen; Lonneke V van de Poll-Franse
Journal:  J Cancer Surviv       Date:  2016-08-01       Impact factor: 4.442

View more
  4 in total

1.  Primary Care Physician Perspectives on Caring for Adult Survivors of Hematologic Malignancies and Hematopoietic Cell Transplantation.

Authors:  Shylaja Mani; Nandita Khera; Lisa Rybicki; Naimisha Marneni; Hetty Carraway; Halle Moore; Helen Whited; Navneet S Majhail
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-11-13

2.  Psychosocial and financial issues after hematopoietic cell transplantation.

Authors:  David Buchbinder; Nandita Khera
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

3.  Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors.

Authors:  Navneet S Majhail; Elizabeth Murphy; Purushottam Laud; Jaime M Preussler; Ellen M Denzen; Beatrice Abetti; Alexia Adams; RaeAnne Besser; Linda J Burns; Jan Cerny; Rebecca Drexler; Theresa Hahn; Lensa Idossa; Balkrishna Jahagirdar; Naynesh Kamani; Alison Loren; Deborah Mattila; Joseph McGuirk; Heather Moore; Jana Reynolds; Wael Saber; Lizette Salazar; Barry Schatz; Patrick Stiff; John R Wingard; Karen L Syrjala; K Scott Baker
Journal:  Haematologica       Date:  2018-12-04       Impact factor: 9.941

4.  Development and Implementation of an Advanced Practitioner-Led Survivorship Clinic for Patients Status Post Allogeneic Transplant.

Authors:  Linda K Baer; Lauren Brister; Susan R Mazanec
Journal:  J Adv Pract Oncol       Date:  2021-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.